title: Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.
abstract: Drug abuse represents a considerable burden of disease and has enormous economic impacts on societies. Over the years, few medications have been developed for clinical use. Their utilization is endowed with several limitations, including partial efficacy or significant side effects. On the other hand, the successful advancement of these compounds provides an important proof of concept for the feasibility of drug development programs in addiction. In recent years, a wealth of information has been generated on the psychological mechanisms, genetic or epigenetic predisposing factors, and neurobiological adaptations induced by drug consumption that interact with each other to contribute to disease progression. It is now clear that addiction develops through phases, from initial recreational use to excessive consumption and compulsive drug seeking, with a shift from positive to negative reinforcement driving motivated behaviors. A greater understanding of these mechanisms has opened new vistas in drug development programs. Researchers' attention has been shifted from investigation of classical targets associated with reward to biological substrates responsible for negative reinforcement, impulse loss of control, and maladaptive mechanisms resulting from protracted drug use. From this research, several new biological targets for the development of innovative therapies have started to emerge. This chapter offers an overview of targets currently under scrutiny for the development of new medications for addiction. This work is not exhaustive but rather it provides a few examples of how this research has advanced in recent years by virtue of studies carried out in our laboratory.
authors.affiliation: School of Pharmacy, Pharmacology Unit, University of Camerino, Camerino, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Ubaldi
authors.affiliation: Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
authors.forename: Nazzareno
authors.initials: N
authors.lastname: Cannella
authors.affiliation: School of Pharmacy, Pharmacology Unit, University of Camerino, Camerino, Italy. Electronic address: roberto.ciccocioppo@unicam.it.
authors.forename: Roberto
authors.initials: R
authors.lastname: Ciccocioppo
mesh_terms: D000818:Animals; D050882:CREB-Binding Protein / Q000235:genetics / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D009479:Neuropeptides / Q000378:metabolism / Q000627:therapeutic use; D009480:Neuropharmacology / Q000379:methods*; D047492:Peroxisome Proliferator-Activated Receptors / Q000235:genetics / Q000378:metabolism; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology
chemical_list: D004791:Enzyme Inhibitors; D009479:Neuropeptides; D047492:Peroxisome Proliferator-Activated Receptors; D050882:CREB-Binding Protein
keywords: CREB; CRF; NK1; NOP; Neurokinins; Neuropeptide S; Nociceptin; Orexin; PPARα; PPARγ; Phosphodiesterase
references.citation: Neuropharmacology. 2014 Jan;76 Pt B:259-68
references.pmid: 23643695
references.citation: Arch Gen Psychiatry. 2004 Mar;61(3):223-9
references.pmid: 14993109
references.citation: Biol Psychiatry. 2010 May 1;67(9):831-9
references.pmid: 20060104
references.citation: Psychopharmacology (Berl). 2011 Nov;218(1):111-9
references.pmid: 21340476
references.citation: J Pharmacol Exp Ther. 2003 Jan;304(1):310-8
references.pmid: 12490606
references.citation: Brain Res Bull. 1991 Feb;26(2):229-33
references.pmid: 1707328
references.citation: Psychopharmacology (Berl). 2009 Oct;206(2):177-85
references.pmid: 19588125
references.citation: J Biol Chem. 2010 Dec 24;285(52):40409-15
references.pmid: 20956526
references.citation: Front Behav Neurosci. 2014 Jun 11;8:212
references.pmid: 24966820
references.citation: Br J Pharmacol. 2011 Feb;162(4):880-9
references.pmid: 20973776
references.citation: Psychopharmacology (Berl). 2003 May;167(3):251-6
references.pmid: 12669178
references.citation: Science. 2001 Nov 2;294(5544):1024-30
references.pmid: 11691979
references.citation: Int J Neuropsychopharmacol. 2013 Oct;16(9):2067-79
references.pmid: 23601187
references.citation: Int J Neuropsychopharmacol. 2014 Sep;17(9):1397-407
references.pmid: 24832929
references.citation: Neuron. 2008 Jul 10;59(1):11-34
references.pmid: 18614026
references.citation: Alcohol. 2009 Aug;43(5):379-86
references.pmid: 19671464
references.citation: Science. 1998 Dec 18;282(5397):2272-5
references.pmid: 9856954
references.citation: J Neurosci. 2011 Nov 9;31(45):16447-57
references.pmid: 22072694
references.citation: Alcohol Clin Exp Res. 2012 Dec;36(12):2157-67
references.pmid: 22671516
references.citation: Neuron. 2006 Feb 16;49(4):589-601
references.pmid: 16476667
references.citation: Science. 2008 Mar 14;319(5869):1536-9
references.pmid: 18276852
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11435-40
references.pmid: 12165570
references.citation: J Biol Chem. 1996 Jun 14;271(24):14163-8
references.pmid: 8662940
references.citation: J Neurosci. 2010 Feb 10;30(6):2300-10
references.pmid: 20147556
references.citation: Regul Pept. 2004 May 15;118(3):183-91
references.pmid: 15003835
references.citation: Biol Psychiatry. 2012 Feb 1;71(3):214-23
references.pmid: 21831361
references.citation: Psychopharmacology (Berl). 2013 Apr;226(4):687-98
references.pmid: 22411428
references.citation: Biol Psychiatry. 2008 Aug 1;64(3):211-8
references.pmid: 18367152
references.citation: J Comp Neurol. 1999 Jun 7;408(3):365-77
references.pmid: 10340512
references.citation: Psychopharmacology (Berl). 2004 Dec;177(1-2):111-20
references.pmid: 15167979
references.citation: Alcohol Clin Exp Res. 2010 Jan;34(1):90-7
references.pmid: 19860802
references.citation: J Biol Chem. 1999 Jun 25;274(26):18438-45
references.pmid: 10373451
references.citation: J Neuroendocrinol. 2001 May;13(5):421-4
references.pmid: 11328451
references.citation: Nat Rev Neurosci. 2011 Oct 20;12(11):670-84
references.pmid: 22011682
references.citation: J Neurosci. 2002 Sep 15;22(18):7856-61
references.pmid: 12223538
references.citation: Psychopharmacology (Berl). 2007 Jun;192(3):385-96
references.pmid: 17297634
references.citation: Brain Res. 1996 Mar 25;713(1-2):114-24
references.pmid: 8724982
references.citation: Neurosci Lett. 2005 Dec 16;390(1):42-7
references.pmid: 16125318
references.citation: Nature. 1990 Oct 18;347(6294):645-50
references.pmid: 2129546
references.citation: Peptides. 2013 Aug;46:6-12
references.pmid: 23684726
references.citation: Neuropsychopharmacology. 2009 Aug;34(9):2125-34
references.pmid: 19322167
references.citation: Psychopharmacology (Berl). 2013 Mar;226(2):347-55
references.pmid: 23149909
references.citation: Neurosci Lett. 2009 Oct 30;464(3):188-92
references.pmid: 19699779
references.citation: Psychopharmacology (Berl). 2004 Mar;172(2):170-8
references.pmid: 14624331
references.citation: J Comp Neurol. 2007 Jan 1;500(1):84-102
references.pmid: 17099900
references.citation: Neuron. 1998 Sep;21(3):467-76
references.pmid: 9768834
references.citation: J Comp Neurol. 2000 Dec 11;428(2):191-212
references.pmid: 11064361
references.citation: Psychopharmacology (Berl). 2006 Dec;189(2):175-86
references.pmid: 17047935
references.citation: Life Sci. 2007 Aug 23;81(11):906-15
references.pmid: 17765929
references.citation: Pharmacol Biochem Behav. 1990 Dec;37(4):839-41
references.pmid: 1709506
references.citation: Neuropsychopharmacology. 1997 Nov;17(5):308-16
references.pmid: 9348546
references.citation: Addict Biol. 2009 Apr;14(2):130-43
references.pmid: 19291009
references.citation: Mol Brain. 2014 Sep 25;7:70
references.pmid: 25252626
references.citation: Lancet. 2005 Jan 8-14;365(9454):167-75
references.pmid: 15639300
references.citation: Brain Res. 2006 Aug 2;1102(1):135-44
references.pmid: 16806114
references.citation: Exp Physiol. 2007 Jul;92(4):671-6
references.pmid: 17468202
references.citation: Methods Find Exp Clin Pharmacol. 1998 Sep;20(7):619-25
references.pmid: 9819808
references.citation: Mol Psychiatry. 2006 Jun;11(6):594-602
references.pmid: 16550213
references.citation: Adv Ther. 2009 Sep;26(9):813-25
references.pmid: 19768639
references.citation: Neurobiol Aging. 2001 Nov-Dec;22(6):937-44
references.pmid: 11755002
references.citation: J Neurosci. 1995 Aug;15(8):5439-47
references.pmid: 7643193
references.citation: Neuropsychopharmacology. 2014 Oct;39(11):2601-10
references.pmid: 24863033
references.citation: Neuroreport. 2001 Dec 21;12(18):4133-7
references.pmid: 11742252
references.citation: Psychopharmacology (Berl). 2008 Jul;199(1):109-17
references.pmid: 18470506
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17198-203
references.pmid: 17921249
references.citation: Life Sci. 2004 Feb 6;74(12):1445-63
references.pmid: 14729395
references.citation: Synapse. 2001 Jun 1;40(3):201-14
references.pmid: 11304758
references.citation: Psychopharmacology (Berl). 2010 Mar;209(1):103-11
references.pmid: 20112009
references.citation: Neurosci Lett. 1992 Dec 14;148(1-2):211-5
references.pmid: 1284443
references.citation: Recent Dev Alcohol. 2003;16:263-81
references.pmid: 12638642
references.citation: Curr Med Chem. 2014 Apr;21(10):1171-87
references.pmid: 24372206
references.citation: Biol Psychiatry. 2007 Jan 1;61(1):78-86
references.pmid: 16876134
references.citation: Neuron. 1995 Apr;14(4):813-23
references.pmid: 7718243
references.citation: Stress. 2000 May;3(3):209-20
references.pmid: 10938582
references.citation: Ann N Y Acad Sci. 2001 Jun;937:132-9
references.pmid: 11458534
references.citation: Psychopharmacology (Berl). 1999 Jul;145(1):21-30
references.pmid: 10445369
references.citation: PLoS One. 2010 Sep 01;5(9):null
references.pmid: 20824145
references.citation: Addict Biol. 2006 Sep;11(3-4):339-55
references.pmid: 16961763
references.citation: Cell. 1998 Feb 20;92(4):573-85
references.pmid: 9491897
references.citation: Neuron. 2012 Oct 4;76(1):192-208
references.pmid: 23040815
references.citation: Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7071-6
references.pmid: 10359840
references.citation: Science. 1997 Jun 27;276(5321):2050-4
references.pmid: 9197270
references.citation: J Neurosci. 1998 Mar 1;18(5):1848-59
references.pmid: 9465009
references.citation: Nature. 1995 Oct 12;377(6549):532-5
references.pmid: 7566152
references.citation: Biol Psychiatry. 2011 Apr 1;69(7):633-41
references.pmid: 20801430
references.citation: J Neurosci. 1998 Dec 1;18(23):9996-10015
references.pmid: 9822755
references.citation: Biol Psychiatry. 2016 Mar 15;79(6):452-62
references.pmid: 26055195
references.citation: Annu Rev Pharmacol Toxicol. 2004;44:525-57
references.pmid: 14744257
references.citation: Brain Res Mol Brain Res. 1998 Mar 1;54(2):183-98
references.pmid: 9555006
references.citation: Cell. 2007 Oct 19;131(2):405-18
references.pmid: 17956739
references.citation: Neurosci Lett. 2012 Sep 6;525(1):1-6
references.pmid: 22884617
references.citation: Curr Pharm Des. 2015;21(3):378-88
references.pmid: 25159072
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1912-7
references.pmid: 11172050
references.citation: Am J Addict. 2000 Fall;9(4):285-313
references.pmid: 11155784
references.citation: Pharmacol Biochem Behav. 2007 Apr;86(4):813-21
references.pmid: 17482248
references.citation: Eur J Pharmacol. 2000 Sep 15;404(1-2):153-9
references.pmid: 10980274
references.citation: J Comp Neurol. 2000 Jul 31;423(3):500-11
references.pmid: 10870089
references.citation: Nature. 2005 Sep 22;437(7058):556-9
references.pmid: 16100511
references.citation: Behav Brain Res. 2007 Oct 1;183(1):43-51
references.pmid: 17599478
references.citation: Neuroscience. 2008 Aug 26;155(3):597-602
references.pmid: 18634857
references.citation: Br J Pharmacol. 2008 May;154(2):327-42
references.pmid: 18345022
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8677-82
references.pmid: 8710930
references.citation: Neuropsychopharmacology. 2012 Jul;37(8):1838-47
references.pmid: 22453137
references.citation: Gene. 1999 Jun 24;234(1):109-17
references.pmid: 10393245
references.citation: Science. 1995 Nov 3;270(5237):792-4
references.pmid: 7481766
references.citation: Addict Biol. 2013 Mar;18(2):332-43
references.pmid: 22260216
references.citation: J Pharmacol Exp Ther. 2005 Dec;315(3):1338-45
references.pmid: 16144971
references.citation: Behav Brain Res. 2007 Aug 6;181(2):232-8
references.pmid: 17540463
references.citation: Neuropharmacology. 2013 Dec;75:437-44
references.pmid: 23973318
references.citation: Front Neuroendocrinol. 2014 Apr;35(2):234-44
references.pmid: 24456850
references.citation: Pharmacol Biochem Behav. 2002 May;72(1-2):213-20
references.pmid: 11900791
references.citation: Curr Drug Targets. 2007 Jan;8(1):137-46
references.pmid: 17266537
references.citation: Endocrinology. 2009 Feb;150(2):707-12
references.pmid: 18845632
references.citation: Behav Pharmacol. 2002 May;13(3):229-35
references.pmid: 12122313
references.citation: Neuropsychopharmacology. 2014 Jun;39(7):1722-31
references.pmid: 24549104
references.citation: Neuroscience. 2004;123(1):131-45
references.pmid: 14667448
references.citation: Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S17-21
references.pmid: 14704738
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references.pmid: 19710631
references.citation: Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7
references.pmid: 9419374
references.citation: J Psychopharmacol. 2012 Oct;26(10):1375-82
references.pmid: 22596207
references.citation: Carcinogenesis. 1998 Jan;19(1):43-8
references.pmid: 9472691
references.citation: Prog Neurobiol. 2013 Jan;100:48-59
references.pmid: 23041581
references.citation: Peptides. 2006 Dec;27(12 ):3299-306
references.pmid: 17097763
references.citation: Peptides. 2000 Jul;21(7):1125-30
references.pmid: 10998547
references.citation: Brain Res. 2003 Jun 13;975(1-2):10-21
references.pmid: 12763589
references.citation: Neuroscience. 2005;132(4):1173-85
references.pmid: 15857719
references.citation: Circ Res. 2007 Jun 8;100(11):1650-8
references.pmid: 17495222
references.citation: J Endocrinol. 1978 Jan;76(1):183-4
references.pmid: 203643
references.citation: J Neurosci. 2013 Jun 12;33(24):10132-42
references.pmid: 23761908
references.citation: Biol Psychiatry. 2011 Apr 1;69(7):642-9
references.pmid: 21276964
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19168-73
references.pmid: 16357203
references.citation: Alcohol Clin Exp Res. 2008 Sep;32(9):1535-42
references.pmid: 18631323
references.citation: J Neurosci. 2004 Dec 15;24(50):11439-48
references.pmid: 15601950
references.citation: Neuroreport. 2001 May 8;12 (6):1145-9
references.pmid: 11338181
references.citation: Neuroscience. 1995 Jan;64(2):419-25
references.pmid: 7535403
references.citation: J Psychopharmacol. 2015 Aug;29(8):878-83
references.pmid: 25744621
references.citation: Eur J Pharmacol. 1999 Apr 9;370(2):93-9
references.pmid: 10323256
references.citation: Neuropsychopharmacology. 2015 Mar 13;40(5):1053-63
references.pmid: 25409596
references.citation: Addict Biol. 2007 Mar;12(1):30-4
references.pmid: 17407495
references.citation: Eur J Neurosci. 2004 May;19(9):2561-8
references.pmid: 15128409
references.citation: Pharmacol Biochem Behav. 2008 Feb;88(4):497-510
references.pmid: 18031798
references.citation: Pharmacol Biochem Behav. 2012 Dec;103(2):332-7
references.pmid: 22982682
references.citation: Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19567-72
references.pmid: 20974945
references.citation: Addict Biol. 2016 Jul;21(4):859-72
references.pmid: 26037332
references.citation: Amino Acids. 2006 Oct;31(3):251-72
references.pmid: 16820980
references.citation: Neuropsychopharmacology. 1999 Sep;21(3):435-44
references.pmid: 10457541
references.citation: J Biol Chem. 1998 Mar 6;273(10):5678-84
references.pmid: 9488698
references.citation: Brain Res. 1999 Jun 19;832(1-2):168-70
references.pmid: 10375664
references.citation: Psychopharmacology (Berl). 1999 Jan;141(2):220-4
references.pmid: 9952048
references.citation: Peptides. 2009 Feb;30(2):234-40
references.pmid: 18992779
references.citation: J Neurosci. 2003 Sep 10;23(23):8271-80
references.pmid: 12967989
references.citation: Neuropharmacology. 2002 Dec;43(8):1258-68
references.pmid: 12527475
references.citation: Neuropharmacology. 2013 Jul;70:236-46
references.pmid: 23415633
references.citation: Biol Psychiatry. 2008 Jan 15;63(2):139-45
references.pmid: 17585886
references.citation: Neuropsychopharmacology. 2008 Mar;33(4):877-91
references.pmid: 17522627
references.citation: Addict Biol. 2013 May;18(3):467-79
references.pmid: 22804785
references.citation: Nat Rev Neurosci. 2015 May;16(5):305-12
references.pmid: 25873042
references.citation: Psychopharmacology (Berl). 2000 Jun;150(3):317-24
references.pmid: 10923760
references.citation: Pharmacol Biochem Behav. 1999 Jan;62(1):151-8
references.pmid: 9972858
references.citation: J Comp Neurol. 1995 May 8;355(3):418-26
references.pmid: 7636023
references.citation: Biol Psychiatry. 2008 Jan 15;63(2):152-7
references.pmid: 17570346
references.citation: Biol Psychiatry. 2009 May 15;65(10):857-62
references.pmid: 19251246
references.citation: Pharmacol Rev. 2006 Sep;58(3):488-520
references.pmid: 16968949
references.citation: J Neurosci. 1997 Oct 15;17(20):7890-901
references.pmid: 9315909
references.citation: Trends Neurosci. 2005 Aug;28(8):436-45
references.pmid: 15982754
references.citation: J Med Chem. 2011 Apr 28;54(8):2687-700
references.pmid: 21438532
references.citation: Neuron. 2004 Aug 19;43(4):487-97
references.pmid: 15312648
references.citation: Bioorg Med Chem Lett. 2015 Aug 1;25(15):2875-87
references.pmid: 26045032
references.citation: Alcohol Clin Exp Res. 2013 Aug;37(8):1351-60
references.pmid: 23550625
references.citation: Addict Biol. 2015 May;20(3):605-16
references.pmid: 24754478
references.citation: Eur Neuropsychopharmacol. 2007 May-Jun;17(6-7):377-93
references.pmid: 17169534
references.citation: Br J Pharmacol. 2006 Jul;148(6):752-9
references.pmid: 16751790
references.citation: Alcohol Clin Exp Res. 2008 Aug;32(8):1380-7
references.pmid: 18564106
references.citation: Pharmacol Ther. 2014 Mar;141(3):283-99
references.pmid: 24189487
references.citation: Nat Neurosci. 2005 Nov;8(11):1437-9
references.pmid: 16251983
references.citation: Eur J Pharmacol. 2009 Oct 12;620(1-3):1-8
references.pmid: 19683523
references.citation: Eur J Pharmacol. 2006 Mar 27;535(1-3):172-6
references.pmid: 16545369
references.citation: Eur Urol. 2015 Oct;68(4):674-80
references.pmid: 25817916
references.citation: Brain Struct Funct. 2012 Apr;217(2):233-56
references.pmid: 21935673
references.citation: Addict Biol. 2007 Sep;12(3-4):227-462
references.pmid: 17678505
references.citation: Drug Alcohol Depend. 2013 Mar 1;128(3):175-86
references.pmid: 23294766
references.citation: Synapse. 1999 Jun 15;32(4):254-61
references.pmid: 10332801
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19480-5
references.pmid: 19033203
references.citation: FEBS Lett. 1998 Oct 30;438(1-2):71-5
references.pmid: 9821961
references.citation: Neuropsychopharmacology. 2005 Sep;30(9):1662-9
references.pmid: 15726114
references.citation: Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):231-6
references.pmid: 15379590
references.citation: Ann N Y Acad Sci. 2001 Jun;937:1-26
references.pmid: 11458532
references.citation: Nature. 2000 May 11;405(6783):180-3
references.pmid: 10821273
references.citation: Neuroreport. 2003 Dec 19;14 (18):2383-5
references.pmid: 14663196
references.citation: Psychopharmacology (Berl). 2008 Feb;196(3):473-82
references.pmid: 17965976
references.citation: Neuroscience. 1995 Feb;64(4):1045-55
references.pmid: 7538637
references.citation: Psychopharmacology (Berl). 2001 Dec;158(4):374-81
references.pmid: 11797058
references.citation: Biol Psychiatry. 2010 Aug 1;68(3):256-64
references.pmid: 20570248
references.citation: Neuropsychopharmacology. 2015 Mar;40(4):927-37
references.pmid: 25311134
references.citation: Annu Rev Med. 2002;53:409-35
references.pmid: 11818483
references.citation: Addict Biol. 2015 Jul;20(4):643-51
references.pmid: 24930632
references.citation: J Neurochem. 2003 Jun;85(6):1604-13
references.pmid: 12787079
references.citation: J Neurosci. 2006 Nov 1;26(44):11324-32
references.pmid: 17079660
references.citation: Alcohol Clin Exp Res. 2011 Apr;35(4):747-55
references.pmid: 21223310
references.citation: Neuroreport. 1998 Jul 13;9(10 ):2243-7
references.pmid: 9694207
references.citation: Int J Neuropsychopharmacol. 2013 Sep;16(8):1867-75
references.pmid: 23590881
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: J Neurosci. 2009 Apr 1;29(13):4155-61
references.pmid: 19339610
references.citation: J Neurosci Res. 2004 Sep 15;77(6):884-91
references.pmid: 15334606
references.citation: Endocrinology. 2006 Jul;147(7):3510-8
references.pmid: 16574794
references.citation: Alcohol Clin Exp Res. 2015 Jan;39(1):136-45
references.pmid: 25516156
references.citation: Eur J Neurosci. 2009 Aug;30(3):493-503
references.pmid: 19656173
references.citation: J Neurosci. 2007 Mar 7;27(10):2718-26
references.pmid: 17344409
references.citation: Alcohol. 2004 Feb;32(2):101-11
references.pmid: 15163561
references.citation: Addict Biol. 2006 Mar;11(1):2-38
references.pmid: 16759333
references.citation: Science. 1996 Aug 2;273(5275):657-9
references.pmid: 8662559
references.citation: Neuroreport. 2000 Jun 26;11(9):1939-43
references.pmid: 10884047
references.citation: Front Biosci. 2008 Jan 01;13:1813-26
references.pmid: 17981670
references.citation: Biochim Biophys Acta. 2011 Aug;1812(8):1007-22
references.pmid: 21382489
references.citation: Nat Rev Neurosci. 2011 Oct 12;12(11):623-37
references.pmid: 21989194
references.citation: Ann N Y Acad Sci. 2008 Nov;1144:61-73
references.pmid: 19076365
references.citation: Curr Opin Drug Discov Devel. 2009 Jul;12(4):458-67
references.pmid: 19562642